Literature DB >> 25864646

Diverse array-designed modes of combination therapies in Fangjiomics.

Jun Liu1, Zhong Wang1.   

Abstract

In line with the complexity of disease networks, diverse combination therapies have been demonstrated potential in the treatment of different patients with complex diseases in a personal combination profile. However, the identification of rational, compatible and effective drug combinations remains an ongoing challenge. Based on a holistic theory integrated with reductionism, Fangjiomics systematically develops multiple modes of array-designed combination therapies. We define diverse "magic shotgun" vertical, horizontal, focusing, siege and dynamic arrays according to different spatiotemporal distributions of hits on targets, pathways and networks. Through these multiple adaptive modes for treating complex diseases, Fangjiomics may help to identify rational drug combinations with synergistic or additive efficacy but reduced adverse side effects that reverse complex diseases by reconstructing or rewiring multiple targets, pathways and networks. Such a novel paradigm for combination therapies may allow us to achieve more precise treatments by developing phenotype-driven quantitative multi-scale modeling for rational drug combinations.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25864646      PMCID: PMC4594182          DOI: 10.1038/aps.2014.125

Source DB:  PubMed          Journal:  Acta Pharmacol Sin        ISSN: 1671-4083            Impact factor:   6.150


  89 in total

1.  Linking PharmGKB to phenotype studies and animal models of disease for drug repurposing.

Authors:  Robert Hoehndorf; Anika Oellrich; Dietrich Rebholz-Schuhmann; Paul N Schofield; Georgios V Gkoutos
Journal:  Pac Symp Biocomput       Date:  2012

2.  Understanding cancer mechanisms through network dynamics.

Authors:  Tammy M K Cheng; Sakshi Gulati; Rudi Agius; Paul A Bates
Journal:  Brief Funct Genomics       Date:  2012-07-18       Impact factor: 4.241

3.  Hypothesis generation in signaling networks.

Authors:  Derek A Ruths; Luay Nakhleh; M Sriram Iyengar; Shrikanth A G Reddy; Prahlad T Ram
Journal:  J Comput Biol       Date:  2006-11       Impact factor: 1.479

4.  Abiraterone acetate plus prednisone versus prednisone alone in chemotherapy-naive men with metastatic castration-resistant prostate cancer: patient-reported outcome results of a randomised phase 3 trial.

Authors:  Ethan Basch; Karen Autio; Charles J Ryan; Peter Mulders; Neal Shore; Thian Kheoh; Karim Fizazi; Christopher J Logothetis; Dana Rathkopf; Matthew R Smith; Paul N Mainwaring; Yanni Hao; Thomas Griffin; Susan Li; Michael L Meyers; Arturo Molina; Charles Cleeland
Journal:  Lancet Oncol       Date:  2013-09-25       Impact factor: 41.316

Review 5.  Apoptosome dysfunction in human cancer.

Authors:  K M Hajra; J R Liu
Journal:  Apoptosis       Date:  2004-11       Impact factor: 4.677

Review 6.  Systems pharmacology: network analysis to identify multiscale mechanisms of drug action.

Authors:  Shan Zhao; Ravi Iyengar
Journal:  Annu Rev Pharmacol Toxicol       Date:  2012       Impact factor: 13.820

7.  Drug synergy screen and network modeling in dedifferentiated liposarcoma identifies CDK4 and IGF1R as synergistic drug targets.

Authors:  Martin L Miller; Evan J Molinelli; Jayasree S Nair; Tahir Sheikh; Rita Samy; Xiaohong Jing; Qin He; Anil Korkut; Aimee M Crago; Samuel Singer; Gary K Schwartz; Chris Sander
Journal:  Sci Signal       Date:  2013-09-24       Impact factor: 8.192

8.  Sequential application of anticancer drugs enhances cell death by rewiring apoptotic signaling networks.

Authors:  Michael J Lee; Albert S Ye; Alexandra K Gardino; Anne Margriet Heijink; Peter K Sorger; Gavin MacBeath; Michael B Yaffe
Journal:  Cell       Date:  2012-05-11       Impact factor: 41.582

9.  Control centrality and hierarchical structure in complex networks.

Authors:  Yang-Yu Liu; Jean-Jacques Slotine; Albert-László Barabási
Journal:  PLoS One       Date:  2012-09-27       Impact factor: 3.240

Review 10.  Computational methods for drug design and discovery: focus on China.

Authors:  Mingyue Zheng; Xian Liu; Yuan Xu; Honglin Li; Cheng Luo; Hualiang Jiang
Journal:  Trends Pharmacol Sci       Date:  2013-09-11       Impact factor: 14.819

View more
  13 in total

1.  Fangjiomics: revealing adaptive omics pharmacological mechanisms of the myriad combination therapies to achieve personalized medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Bo-li Zhang; Yong-yan Wang
Journal:  Acta Pharmacol Sin       Date:  2015-06       Impact factor: 6.150

2.  New omic and network paradigms for deep understanding of therapeutic mechanisms for Fangji of traditional Chinese medicine.

Authors:  Dayue Darrel Duan; Zhong Wang; Yong-Yan Wang
Journal:  Acta Pharmacol Sin       Date:  2018-06       Impact factor: 6.150

3.  Entropy-based divergent and convergent modular pattern reveals additive and synergistic anticerebral ischemia mechanisms.

Authors:  Yanan Yu; Xiaoxu Zhang; Bing Li; Yingying Zhang; Jun Liu; Haixia Li; Yinying Chen; Pengqian Wang; Ruixia Kang; Hongli Wu; Zhong Wang
Journal:  Exp Biol Med (Maywood)       Date:  2016-08-10

4.  Yangxin Tongmai Formula ameliorates impaired glucose tolerance in children with Graves' disease through upregulation of the insulin receptor levels.

Authors:  Yan-Hong Luo; Min Zhu; Dong-Gang Wang; Yu-Sheng Yang; Tao Tan; Hua Zhu; Jian-Feng He
Journal:  Acta Pharmacol Sin       Date:  2017-11-23       Impact factor: 6.150

5.  Pure mechanistic analysis of additive neuroprotective effects between baicalin and jasminoidin in ischemic stroke mice.

Authors:  Peng-Qian Wang; Qiong Liu; Wen-Juan Xu; Ya-Nan Yu; Ying-Ying Zhang; Bing Li; Jun Liu; Zhong Wang
Journal:  Acta Pharmacol Sin       Date:  2018-01-18       Impact factor: 6.150

6.  Network-Wide Screen Identifies Variation of Novel Precise On-Module Targets Using Conformational Modudaoism.

Authors:  Bing Li; Jun Liu; Yanan Yu; Pengqian Wang; Yingying Zhang; Xumin Ni; Qiong Liu; Xiaoxu Zhang; Zhong Wang; Yongyan Wang
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2017-11-20

Review 7.  Development of Fangjiomics for Systems Elucidation of Synergistic Mechanism Underlying Combination Therapy.

Authors:  Peng-Lu Wei; Hao Gu; Jun Liu; Zhong Wang
Journal:  Comput Struct Biotechnol J       Date:  2018-11-20       Impact factor: 7.271

8.  Intermodule Coupling Analysis of Huang-Lian-Jie-Du Decoction on Stroke.

Authors:  Pengqian Wang; Li Dai; Weiwei Zhou; Jing Meng; Miao Zhang; Yin Wu; Hairu Huo; Xingjiang Xiong; Feng Sui
Journal:  Front Pharmacol       Date:  2019-11-05       Impact factor: 5.810

9.  ETCM: an encyclopaedia of traditional Chinese medicine.

Authors:  Hai-Yu Xu; Yan-Qiong Zhang; Zhen-Ming Liu; Tong Chen; Chuan-Yu Lv; Shi-Huan Tang; Xiao-Bo Zhang; Wei Zhang; Zhi-Yong Li; Rong-Rong Zhou; Hong-Jun Yang; Xiu-Jie Wang; Lu-Qi Huang
Journal:  Nucleic Acids Res       Date:  2019-01-08       Impact factor: 16.971

10.  Similarity of therapeutic networks induced by a multi-component herbal remedy, Ukgansan, in neurovascular unit cells.

Authors:  Bu-Yeo Kim; Hye-Sun Lim; Yu Jin Kim; Eunjin Sohn; Yun Hee Kim; Imhoi Koo; Soo-Jin Jeong
Journal:  Sci Rep       Date:  2020-02-14       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.